A new study found that Indianapolis-area hospitals are charging patients insured by their employers 264 percent more for outpatient services than the federal Medicare program pays for the exact same services at the same hospitals.
Gov. Mike Pence’s go-slow approach could push an expansion of Medicaid eligibility in Indiana to the end of 2014. And he’s OK with that.
The remnants of ill-fated Elona Biotechnologies Inc. will be auctioned on Sept. 27, presenting a rare turnkey opportunity for entrepreneurs interested in jumping into the life sciences industry.
Medicare data show some county-owned hospitals around Indianapolis scored better than big-name hospitals like IU Health and Community.
Patients, in spite of what it may feel like, pay only a tiny fraction of the total health care bill directly from their own pockets. It’s no wonder then that prices and good service are hard to find.
The ‘modest’ 4 percent rise in health insurance premiums, when compared with wages, shows things are getting worse, not better, for health care consumers.
How would a single-payer national health insurance program change the finances for employers, workers, doctors and hospitals?
In this age of austerity, there’s almost no chance of Indianapolis hospitals creating a Cleveland Clinic-like hub of innovation.
Starting with this post, I’m going to periodically give you a peek at my reading list. I’ll highlight reports and reportage that I have found either helpful or provocative. I hope you do, too.
The local orthopedic surgeons are presenting themselves as low-cost providers in an attempt to reverse growth restrictions imposed by Obamacare.
By and large, Obamacare will leave in place the same major problems in the health care systems that existed before the law was passed—in both Indiana and across the nation.
Michael Evans was juggling two companies and two newborn twins when his board of directors suggested it was time for a new CEO of AIT Laboratories. He was replaced by venture capitalist Matt Neff on Monday.
Obamacare is destined to fail for one key reason: it will make health insurance cost more and buy less.
Venture capital surged in the first half of 2012, to $51.6 million in Indiana. But the pace of activity here fell off sharply in the second half of last year, and remained sluggish into 2013.
This is the first of three blog posts, each of which will make a compelling case for one of three distinct positions on Obamacare in Indiana: why it will succeed, why it will fail and why it will be a “non-event.”
Digging into the filings by health insurers, I concluded that half of Hoosiers buying individual coverage next year on exchanges will pay less than before Obamacare. The other half will pay more.
Zimmer Holdings saw second-quarter earnings slump 29 percent as the orthopedic device maker set aside an additional $47 million to cover the cost of lawsuits related to its Durom hip cups.
The Indianapolis-based maker of agricultural products, a unit of Michigan-based Dow Chemical Co., said revenue increased 10 percent from the year-ago period.
Even as it tries narrow networks, health insurer is trying to offer more choice of doctors now, but push for lower provider payments later.
